NKG7 and melanoma: Moreover, we analyzed the expression level of gene CD3E, CD4, CD8A, GZMB, NKG7, TCF7 and TRBC2, the well-known markers for CD8+ T cells, and they were all shown to have significantly higher expression level in melanoma patients with low risk (Figure 4C).